Evaluation of the Bio-Rad Multispot HIV-1/HIV-2 Rapid Test as an alternative to Western blot for confirmation of HIV infection

Journal of Clinical Virology

Volumn 58, Issue SUPPL1, 2013, Pages

  Cárdenas, Ana María ^a   Baughan, Eleonore ^a   Hodinka, Richard L ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Algorithm; CAP; CRF; Diagnosis; HIV; Ind; Mo.; ND; Neg; NR; Pos; R; Rapid test; Western blot

Indexed keywords

ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RAPID TEST; SEROCONVERSION; WESTERN BLOTTING;

ALGORITHM; CAP; CIRCULATING RECOMBINANT FORMS; COLLEGE OF AMERICAN PATHOLOGY; CRF; DIAGNOSIS; HIV; IND; INDETERMINATE; MO.; MONTHS; ND; NEG; NEGATIVE; NONREACTIVE; NOT DONE; NR; POS; POSITIVE; R; RAPID TEST; REACTIVE; WESTERN BLOT;

ALGORITHMS; BLOTTING, WESTERN; CLINICAL LABORATORY TECHNIQUES; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; INFANT; INFANT, NEWBORN; MALE; SEROLOGIC TESTS; TIME FACTORS; UNITED STATES; VIROLOGY;

EID: 84890201867     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.08.021     Document Type: Article

References (34)

1. Centers for Disease Control and Prevention Perspectives in disease prevention and health promotion: public health service guidelines for counseling and antibody testing to prevent HIV infection and AIDS. MMWR Morb Mortal Wkly Rep 1987, 36:509-515.
2. Clinical and Laboratory Standards Institute Criteria for laboratory testing and diagnosis of human immunodeficiency virus infection; approved guideline. CLSI document M53-A 2011, Clinical and Laboratory Standards Institute, Wayne, PA.
3. Fiebig E.W., Wright D.J., Rawal B.D., Garrett P.E., Schumacher R.T., Peddada L., et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003, 17:1871-1879.
4. Chappel R.J., Wilson K.M., Dax E.M. Immunoassays for the diagnosis of HIV: meeting future needs by enhancing the quality of testing. Future Microbiol 2009, 4:963-982.
5. Pandori M.W., Hackett J., Louie B., Vallari A., Dowling T., Liska S., et al. Assessment of the ability of a fourth-generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting. J Clin Microbiol 2009, 47:2639-2642.
6. Eshleman S.H., Khaki L., Laeyendecker O., Piwowar-Manning E., Johnson-Lewis L., Husnik M., et al. Detection of individuals with acute HIV-1 infection using the ARCHITECT HIV Ag/Ab Combo assay. J Acquir Immune Defic Syndr 2009, 52:121-124.
7. Centers for Disease Control and Prevention HIV-2 infection surveillance-United States, 1987-2009. MMWR Morb Mortal Wkly Rep 2011, 60:985-988.
8. Guan M. Frequency, causes, and new challenges of indeterminate results in Western blot confirmatory testing for antibodies to human immunodeficiency virus. Clin Vaccine Immunol 2007, 14:649-659.
9. Torian L.V., Eavey J.J., Punsalang A.P., Pirillo R.E., Forgione L.A., Kent S.A., et al. HIV type 2 in New York City, 2000-2008. Clin Infect Dis 2010, 51:1334-1342.
10. De Cock K.M., Porter A., Kouadio J., Maran M., Lafontaine M.F., Gershy-Damet G.M., et al. Cross-reactivity on western blots in HIV-1 and HIV-2 infections. AIDS 1991, 5:859-863.
11. Branson B.M. The future of HIV testing. J Acquir Immune Defic Syndr 2010, 55S:S102-S105.
12. Delaney K.P., Heffelfinger J.D., Wesolowski L.G., Owen S.M., Meyer W.A., Kennedy S., et al. Performance of an alternative laboratory-based algorithm for HIV diagnosis in a high-risk population. J Clin Virol 2011, 52S:S5-S10.
13. Masciotra S., McDougal J.S., Feldman J., Sprinkle P., Wesolowski L., Owen S.M. Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections. J Clin Virol 2011, 52S:S17-S22.
14. Styer L.M., Sullivan T.J., Parker M.M. Evaluation of an alternative supplemental testing strategy for HIV diagnosis by retrospective analysis of clinical HIV testing data. J Clin Virol 2011, 52S:S35-S40.
15. Wesolowski L.G., Delaney K.P., Hart C., Dawson C., Owen S.M., Candal D., et al. Performance of an alternative laboratory-based algorithm for diagnosis of HIV infection utilizing a third generation immunoassay, a rapid HIV-1/HIV-2 differentiation test and a DNA or RNA-based nucleic acid amplification test in persons with established HIV-1 infection and blood donors. J Clin Virol 2011, 52S:S45-S49.
16. Chavez P., Wesolowski L., Patel P., Delaney K., Owen S.M. Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay. J Clin Virol 2011, 52S:S51-S55.
17. Bentsen C., McLaughlin L., Mitchell E., Ferrera C., Liska S., Myers R., et al. Performance evaluation of the Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA, a 4th generation HIV assay for the simultaneous detection of HIV p24 antigen and antibodies to HIV-1 (groups M and O) and HIV-2 in human serum and plasma. J Clin Virol 2011, 52S:S57-S61.
18. Nasrullah M., Wesolowski L.G., Meyer W.A., Owen S.M., Masciotra S., Vorwald C., et al. Performance of a fourth-generation HIV screening assay and an alternative HIV diagnostic testing algorithm. AIDS 2013, 27:731-737.
19. Nasrullah M., Ethridge S.F., Delaney K.P., Wesolowski L.G., Granade T.C., Schwendemann J., et al. Comparison of alternative interpretive criteria for the HIV-1 Western blot and results of the Multispot HIV-1/HIV-2 Rapid Test for classifying HIV-1 and HIV-2 infections. J Clin Virol 2011, 52S:S23-S27.
20. Torian L.V., Forgione L.A., Punsalang A.E., Pirillo R.E., Oleszko W.R. Comparison of Multispot EIA with Western blot for confirmatory serodiagnosis of HIV. J Clin Virol 2011, 52S:S41-S44.
21. Pierce V.M., Neide B., Hodinka R.L. Evaluation of the Gen-Probe Aptima HIV-1 RNA qualitative assay as an alternative to Western blot analysis for confirmation of HIV infection. J Clin Microbiol 2011, 49:1642-1645.
22. Ethridge S.F., Wesolowski L.G., Nasrullah M., Kennedy M.S., Delaney K.P., Candal D., et al. Comparative evaluation of Aptima HIV-1 qualitative RNA assay performance using plasma and serum specimens from persons with established HIV-1 infection. J Clin Virol 2011, 52S:S63-S66.
23. Dragavon J., Gallardo C., Espinosa E., Ortega J.P., Harb S., Steckler J., et al. Use of Multispot HIV-1/HIV-2 Rapid Test to confirm HIV-1/HIV-2 Plus O Enzyme Immunoassay results, shorten reporting time for HIV testing and identify cryptic HIV-2 infection. HIV diagnostics conference 2010, http://www.hivtestingconference/.
24. Patel P., Bennett B., Sullivan T., Parker M.M., Heffelinger J.D. Sullivan PS, for the CDC AHI Study Group Rapid HIV screening: missed opportunities for HIV diagnosis and prevention. J Clin Virol 2012, 54:42-47.
25. Cherutich P., Bunnell R., Mermin J. HIV testing: current practice and future directions. Curr HIV/AIDS Rep 2013, 10:134-141.
26. Martin E.G., Salaru G., Paul S.M., Cadoff E.M. Use of a rapid HIV testing algorithm to improve linkage to care. J Clin Virol 2011, 52S::S11-S15.
27. O'Conell R.J., Peel S.A. Multispot HIV-1/HIV-2 Rapid Test: advantages over other rapid HIV tests. Expert Rev Mol Diagn 2007, 7:499-505.
28. Owen S.M., Yang C., Spira T., Ou C.Y., Pau C.P., Parekh B.S., et al. Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States. J Clin Microbiol 2008, 46:1588-1595.
29. Chantry C.J., Cooper E.R., Pelton S.I., Zorilla C., Hillyer G.V., Diaz C. Seroreversion in human immunodeficiency virus-exposed but uninfected infants. Pediatr Infect Dis J 1995, 14:382-387.
30. Abbott Laboratories Architect HIV Ag/Ab Combo reagent package insert 2012, Abbott Laboratories, Abbott Park, IL. http://www.abbottdiagnostics.com/Support/Technical_Library/Package_Inserts/getPIFile.cfm%3FcontrolNumber=G26108.
31. Maxim Biomedical Inc. Cambridge Biotech HIV-1 Western blot kit package insert 2009, Maxim Biomedical Inc., Rockville, MD. http://www.mbidiagnostic.com/images/HIV-1_SERUM_WESTERN_BLOT_KIT_PN98002_PACKAGE_INSERT_REV_06b.pdf.
32. Bio-Rad Laboratories Multispot HIV-1/HIV-2 Rapid Test package insert 2013, Bio-Rad Laboratories, Redmond, WA.
33. Centers for Disease Control and Prevention Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. MMWR Morb Mortal Wkly Rep 1989, 38(Suppl. 7):1-7.
34. American Academy of Pediatrics Human immunodeficiency virus infection. Red Book: 2012 Report on the Committee on Infectious Diseases 2012, 418-439. American Academy of Pediatrics, Grove Village, IL. 29th ed. L.K. Pickering (Ed.).